|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-12-18
|
|
pubmed:abstractText |
We investigated the role of tumor necrosis factor alpha (TNF-alpha) in protamine-induced cardiotoxicity and the possibility of preventing or decreasing this effect by anti TNF-alpha antibodies and heparin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0003-3022
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1389-95
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11748397-Animals,
pubmed-meshheading:11748397-Antibodies, Blocking,
pubmed-meshheading:11748397-Anticoagulants,
pubmed-meshheading:11748397-Heart Diseases,
pubmed-meshheading:11748397-Hemodynamics,
pubmed-meshheading:11748397-Heparin,
pubmed-meshheading:11748397-Heparin Antagonists,
pubmed-meshheading:11748397-Male,
pubmed-meshheading:11748397-Protamines,
pubmed-meshheading:11748397-RNA, Messenger,
pubmed-meshheading:11748397-Rats,
pubmed-meshheading:11748397-Rats, Wistar,
pubmed-meshheading:11748397-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Protamine-induced cardiotoxicity is prevented by anti-TNF-alpha antibodies and heparin.
|
|
pubmed:affiliation |
Department of Thoracic and Cardiovascular Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Israel. pevni@tasmc.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
